TYNDALL CAPITAL PARTNERS L P

Holdings History for Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN)

Symbol
CYCN on Nasdaq
Investment type
Equity / Common Stock, no par value
Latest Disclosed Shares Owned
155,187 shares
Security Ownership %
4.8%
Shares, Excluding Options vs Price
Value, Excluding Options

Tyndall Capital Partners, L.P. ownership in Cyclerion Therapeutics, Inc. Common Stock, no par value (CYCN)

14 Aug 2025 - Tyndall Capital Partners, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 155,187 shares of Cyclerion Therapeutics, Inc. Common Stock, no par value (CYCN). This represents 4.8% ownership of the company. In their previous filing dated 15 May 2025, TYNDALL CAPITAL PARTNERS L P had reported owning 164,777 shares, indicating a decrease of +5.8%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.